Cancer cures are often promised but rarely delivered. In this video, we look at a real clinical trial where a specific drug ...

Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...

Enhertu showed better outcomes in HR-positive, HER2-negative breast cancer, while Trodelvy was more effective in HR-negative, HER2-null tumors when used first. Real-world data from over 4,000 patients ...

Artificial intelligence is stepping into the fight against cancer — and, according to Fox News senior medical analyst Dr. Marc Siegel, it could be a game-changer. On the Monday episode of "Fox & ...

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the Government-funded National Institute for Health and Care Research (NIHR), the trial ...

Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...

"I don't want to overpromise" because "anecdotal reports" may not include failures, Dr. Harvey Risch exclusively tells Just ...

Acupuncture conferred significant, clinically meaningful improvements in both perceived and objective cognitive function for ...

Research highlights the complex cognitive difficulties faced by breast cancer survivors, emphasizing the need for multifaceted treatment approaches.

Real and sham acupuncture were more effective at improving breast cancer survivors' perceived cognitive impairment compared ...